These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12622790)

  • 1. Tyrosinase gene correction using fluorescent oligonucleotides.
    Biet E; Alberti C; Faccella P; Sun JS; Dutreix M; Larue L
    Pigment Cell Res; 2003 Apr; 16(2):133-8. PubMed ID: 12622790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous targeted alteration of the tyrosinase and c-kit genes by single-stranded oligonucleotides.
    Alexeev V; Igoucheva O; Yoon K
    Gene Ther; 2002 Dec; 9(24):1667-75. PubMed ID: 12457280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligonucleotide-mediated gene targeting in human hepatocytes: implications of mismatch repair.
    Igoucheva O; Alexeev V; Anni H; Rubin E
    Oligonucleotides; 2008 Jun; 18(2):111-22. PubMed ID: 18637729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reaction parameters of targeted gene repair in mammalian cells.
    Hu Y; Parekh-Olmedo H; Drury M; Skogen M; Kmiec EB
    Mol Biotechnol; 2005 Mar; 29(3):197-210. PubMed ID: 15767697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene correction by RNA-DNA oligonucleotides.
    Alexeev V; Yoon K
    Pigment Cell Res; 2000 Apr; 13(2):72-9. PubMed ID: 10841028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localized in vivo genotypic and phenotypic correction of the albino mutation in skin by RNA-DNA oligonucleotide.
    Alexeev V; Igoucheva O; Domashenko A; Cotsarelis G; Yoon K
    Nat Biotechnol; 2000 Jan; 18(1):43-7. PubMed ID: 10625389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High efficiency liposome-mediated transfection of the tyrosinase gene to cultured cells: a model for the gene therapy of hair color restoration.
    Li L; Lishko V; Hoffman RM
    In Vitro Cell Dev Biol Anim; 1994 Mar; 30A(3):135-8. PubMed ID: 25939158
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeted gene correction by small single-stranded oligonucleotides in mammalian cells.
    Igoucheva O; Alexeev V; Yoon K
    Gene Ther; 2001 Mar; 8(5):391-9. PubMed ID: 11313816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable and inheritable changes in genotype and phenotype of albino melanocytes induced by an RNA-DNA oligonucleotide.
    Alexeev V; Yoon K
    Nat Biotechnol; 1998 Dec; 16(13):1343-6. PubMed ID: 9853616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3 Decoy ODN Therapy for Cancer.
    Sun X; Zhang J
    Methods Mol Biol; 2015; 1317():167-83. PubMed ID: 26072408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted correction of a chromosomal point mutation by modified single-stranded oligonucleotides in a GFP recovery system.
    Yin WX; Wu XS; Liu G; Li ZH; Watt RM; Huang JD; Liu DP; Liang CC
    Biochem Biophys Res Commun; 2005 Sep; 334(4):1032-41. PubMed ID: 16039616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection of the macrophage cell line NR8383 with Mycobacterium tuberculosis (H37Ra) leads to an increase in oligodeoxynucleotide accumulation.
    Rosenblatt MN; Burns JR; Duncan VE; Hughes JA
    Antisense Nucleic Acid Drug Dev; 2000 Feb; 10(1):1-9. PubMed ID: 10726655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system.
    Kaneda Y; Nakajima T; Nishikawa T; Yamamoto S; Ikegami H; Suzuki N; Nakamura H; Morishita R; Kotani H
    Mol Ther; 2002 Aug; 6(2):219-26. PubMed ID: 12161188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription factor decoy for NFkappaB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis.
    Tomita T; Takano H; Tomita N; Morishita R; Kaneko M; Shi K; Takahi K; Nakase T; Kaneda Y; Yoshikawa H; Ochi T
    Rheumatology (Oxford); 2000 Jul; 39(7):749-57. PubMed ID: 10908694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfection of nuclear factor-kappaB decoy oligodeoxynucleotide protects against ischemia/reperfusion injury in a rat epigastric flap model.
    Uemura T; Tsujii M; Akeda K; Iino T; Satonaka H; Hasegawa M; Sudo A
    J Gene Med; 2012 Nov; 14(11):623-31. PubMed ID: 23080520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NFkappaB decoy oligodeoxynucleotides ameliorates osteoporosis through inhibition of activation and differentiation of osteoclasts.
    Shimizu H; Nakagami H; Tsukamoto I; Morita S; Kunugiza Y; Tomita T; Yoshikawa H; Kaneda Y; Ogihara T; Morishita R
    Gene Ther; 2006 Jun; 13(12):933-41. PubMed ID: 16511526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection method.
    Poston RS; Mann MJ; Hoyt EG; Ennen M; Dzau VJ; Robbins RC
    Transplantation; 1999 Sep; 68(6):825-32. PubMed ID: 10515383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular uptake and ex vivo urothelial penetration by oligodeoxynucleotides for optimizing treatment of transitional cell carcinoma.
    Bolenz C; Trojan L; Gabriel U; Honeck P; Wendt-Nordahl G; Schaaf A; Alken P; Michel MS
    Anal Quant Cytol Histol; 2008 Oct; 30(5):265-73. PubMed ID: 18980158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel method of non-viral efficient gene transfer into neonatal cardiac myocytes.
    Tashiro H; Aoki M; Isobe M; Hashiya N; Makino H; Kaneda Y; Ogihara T; Morishita R
    J Mol Cell Cardiol; 2005 Sep; 39(3):503-9. PubMed ID: 16040050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of decoy oligodeoxynucleotides-based approach to renal diseases.
    Tomita N; Azuma H; Kaneda Y; Ogihara T; Morishita R
    Curr Drug Targets; 2004 Nov; 5(8):717-33. PubMed ID: 15578952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.